Financier | Commitments |
---|---|
IDA GRANT FOR HIV/AIDS | 25.50 |
Borrower/Recipient | 2.50 |
P082957
Closed
Amadou Dem
N/A
April 21, 2004
(as of board presentation)
June 17, 2004
December 30, 2004
US$ 28.00 million
N/A
2004
US$ 25.50 million
B
Not Applicable
March 31, 2012
BANK APPROVED
March 10, 2015
Financier | Commitments |
---|---|
IDA GRANT FOR HIV/AIDS | 25.50 |
Borrower/Recipient | 2.50 |
Product Line | IBRD/IDA |
---|---|
IBRD Commitment | N/A |
IDA Commitment | 25.50 |
IBRD + IDA Commitment | 25.50 |
Lending Instrument | |
---|---|
Grant Amount | N/A |
Total Project Cost** | 28.00 |
Period | Financier | Transaction Type | Amount (US$) |
---|---|---|---|
Sep 22, 2017 | IDA-46250 | Int Charges | 18,335.94 |
Sep 22, 2017 | IDA-46250 | Int Charges | 18,335.94 |
Mar 17, 2017 | IDA-46250 | Int Charges | 14.33 |
Mar 17, 2017 | IDA-46250 | Int Charges | 14.33 |
Mar 17, 2017 | IDA-46250 | Int Charges | 17,820.39 |
Mar 17, 2017 | IDA-46250 | Int Charges | 17,820.39 |
Mar 16, 2018 | IDA-46250 | Int Charges | 435.95 |
Mar 16, 2018 | IDA-46250 | Int Charges | 435.95 |
Mar 16, 2018 | IDA-46250 | Int Charges | 18,856.97 |
Mar 16, 2018 | IDA-46250 | Int Charges | 18,856.97 |
Sep 19, 2018 | IDA-46250 | Int Charges | 292.07 |
Sep 19, 2018 | IDA-46250 | Int Charges | 292.07 |
Sep 19, 2018 | IDA-46250 | Int Charges | 18,454.56 |
Sep 19, 2018 | IDA-46250 | Int Charges | 18,454.56 |
Mar 18, 2019 | IDA-46250 | Int Charges | 16.50 |
Mar 18, 2019 | IDA-46250 | Int Charges | 16.50 |
Mar 18, 2019 | IDA-46250 | Int Charges | 37.86 |
Mar 18, 2019 | IDA-46250 | Int Charges | 37.86 |
Mar 18, 2019 | IDA-46250 | Int Charges | 18,366.68 |
Mar 18, 2019 | IDA-46250 | Int Charges | 18,366.68 |
Sep 15, 2019 | IDA-46250 | Loan Repay | 48.49 |
Sep 15, 2019 | IDA-46250 | Loan Repay | 18.50 |
Sep 18, 2019 | IDA-46250 | Loan Repay | 48,125.06 |
Sep 18, 2019 | IDA-46250 | Int Charges | 18,071.94 |
Sep 18, 2019 | IDA-46250 | Int Charges | 18,071.94 |
Mar 15, 2020 | IDA-46250 | Loan Repay | 647.17 |
Mar 18, 2020 | IDA-46250 | Loan Repay | 47,355.15 |
Mar 18, 2020 | IDA-46250 | Int Charges | 2.99 |
Mar 18, 2020 | IDA-46250 | Int Charges | 2.99 |
Mar 18, 2020 | IDA-46250 | Int Charges | 17,818.53 |
Mar 18, 2020 | IDA-46250 | Int Charges | 17,818.53 |
Oct 13, 2020 | IDA-46250 | Loan Repay | 49,003.09 |
Oct 13, 2020 | IDA-46250 | Int Charges | 3.07 |
Oct 13, 2020 | IDA-46250 | Int Charges | 3.07 |
Oct 13, 2020 | IDA-46250 | Int Charges | 17,089.45 |
Oct 13, 2020 | IDA-46250 | Int Charges | 17,089.45 |
Mar 16, 2021 | IDA-46250 | Int Charges | 28.89 |
Mar 16, 2021 | IDA-46250 | Int Charges | 28.89 |
Mar 16, 2021 | IDA-46250 | Int Charges | 18,285.70 |
Mar 16, 2021 | IDA-46250 | Int Charges | 18,285.70 |
Mar 16, 2021 | IDA-46250 | Int Charges | 1,206.69 |
Mar 16, 2021 | IDA-46250 | Int Charges | 1,206.69 |
Mar 16, 2021 | IDA-46250 | Loan Repay | 50,270.01 |
Sep 15, 2020 | IDA-46250 | Loan Repay | 749.57 |
Mar 15, 2014 | IDA-46250 | Int Charges | 20,232.44 |
Mar 15, 2014 | IDA-46250 | Int Charges | 20,232.44 |
Mar 15, 2014 | IDA-46250 | Int Charges | 270.89 |
Mar 15, 2014 | IDA-46250 | Int Charges | 270.89 |
Sep 25, 2013 | IDA-46250 | Loan Cancel | 893,593.94 |
Sep 15, 2013 | IDA-46250 | Int Charges | 487.67 |
Sep 15, 2013 | IDA-46250 | Int Charges | 487.67 |
Sep 15, 2013 | IDA-46250 | Int Charges | 19,157.23 |
Sep 15, 2013 | IDA-46250 | Int Charges | 19,157.23 |
Sep 15, 2013 | IDA-46250 | Int Charges | 44.99 |
Sep 15, 2013 | IDA-46250 | Int Charges | 44.99 |
Sep 15, 2013 | IDA-46250 | Int Charges | 44.99 |
Sep 15, 2013 | IDA-46250 | Int Charges | 44.99 |
Mar 18, 2015 | IDA-46250 | Int Charges | 17,472.79 |
Mar 18, 2015 | IDA-46250 | Int Charges | 17,472.79 |
Sep 15, 2014 | IDA-46250 | Int Charges | 213.10 |
Sep 15, 2014 | IDA-46250 | Int Charges | 19,778.75 |
Sep 15, 2014 | IDA-46250 | Int Charges | 19,778.75 |
Mar 15, 2015 | IDA-46250 | Int Charges | 604.26 |
Mar 15, 2015 | IDA-46250 | Int Charges | 604.26 |
Sep 15, 2014 | IDA-46250 | Int Charges | 213.10 |
Mar 16, 2016 | IDA-46250 | Int Charges | 179.65 |
Mar 16, 2016 | IDA-46250 | Int Charges | 179.65 |
Sep 17, 2015 | IDA-46250 | Int Charges | 17,682.46 |
Sep 17, 2015 | IDA-46250 | Int Charges | 17,682.46 |
Sep 15, 2015 | IDA-46250 | Int Charges | 749.53 |
Sep 15, 2015 | IDA-46250 | Int Charges | 749.53 |
Sep 21, 2016 | IDA-46250 | Int Charges | 115.16 |
Sep 21, 2016 | IDA-46250 | Int Charges | 115.16 |
Sep 21, 2016 | IDA-46250 | Int Charges | 18,383.09 |
Sep 21, 2016 | IDA-46250 | Int Charges | 18,383.09 |
Mar 16, 2016 | IDA-46250 | Int Charges | 18,245.31 |
Mar 16, 2016 | IDA-46250 | Int Charges | 18,245.31 |
Sep 22, 2017 | IDA-46250 | Int Charges | 77.08 |
Sep 15, 2021 | IDA-46250 | Loan Repay | 49,638.49 |
Sep 15, 2021 | IDA-46250 | Int Charges | 1.06 |
Sep 15, 2021 | IDA-46250 | Int Charges | 1.06 |
Sep 15, 2021 | IDA-46250 | Int Charges | 17,961.08 |
Sep 15, 2021 | IDA-46250 | Int Charges | 17,961.08 |
Sep 15, 2021 | IDA-46250 | Loan Repay | 511.59 |
Oct 4, 2022 | IDA-46250 | Int Charges | 15,968.25 |
Jul 12, 2022 | IDA-46250 | Loan Repay | 46,061.06 |
Jul 12, 2022 | IDA-46250 | Int Charges | 16,409.24 |
Jul 12, 2022 | IDA-46250 | Int Charges | 16,409.24 |
Jul 12, 2022 | IDA-46250 | Int Charges | 85.36 |
Jul 12, 2022 | IDA-46250 | Int Charges | 85.36 |
Sep 15, 2022 | IDA-46250 | Loan Repay | 4,663.81 |
Oct 4, 2022 | IDA-46250 | Loan Repay | 40,660.76 |
Oct 4, 2022 | IDA-46250 | Int Charges | 110.42 |
Oct 4, 2022 | IDA-46250 | Int Charges | 110.42 |
Oct 4, 2022 | IDA-46250 | Int Charges | 15,968.25 |
Apr 6, 2023 | IDA-46250 | Int Charges | 16,497.52 |
Apr 6, 2023 | IDA-46250 | Int Charges | 16,497.52 |
Apr 6, 2023 | IDA-46250 | Loan Repay | 46,475.47 |
Apr 6, 2023 | IDA-46250 | Int Charges | 16.84 |
Apr 6, 2023 | IDA-46250 | Int Charges | 16.84 |
Oct 16, 2023 | IDA-46250 | Int Charges | 40.48 |
Oct 16, 2023 | IDA-46250 | Int Charges | 40.48 |
Oct 16, 2023 | IDA-46250 | Loan Repay | 46,082.16 |
Oct 16, 2023 | IDA-46250 | Int Charges | 19.76 |
Oct 16, 2023 | IDA-46250 | Int Charges | 19.76 |
Oct 16, 2023 | IDA-46250 | Int Charges | 15,898.34 |
Oct 16, 2023 | IDA-46250 | Int Charges | 15,898.34 |
Mar 15, 2023 | IDA-46250 | Loan Repay | 936.58 |
Mar 15, 2024 | IDA-46250 | Loan Repay | 2,041.80 |
Mar 15, 2024 | IDA-46250 | Loan Repay | 5,049.97 |
Apr 18, 2024 | IDA-46250 | Loan Repay | 39,299.43 |
Apr 18, 2024 | IDA-46250 | Int Charges | 29.91 |
Apr 18, 2024 | IDA-46250 | Int Charges | 29.91 |
Apr 18, 2024 | IDA-46250 | Int Charges | 15,804.26 |
Apr 18, 2024 | IDA-46250 | Int Charges | 15,804.26 |
Jun 17, 2004 | IDA-H0990 | Loan Commitment | 25,500,000.00 |
May 19, 2009 | IDA-46250 | Loan Commitment | 6,000,000.00 |
Sep 22, 2017 | IDA-46250 | Int Charges | 77.08 |
Name | Review | Date |
---|---|---|
Procurement | Moderately Satisfactory | 2011-12-28 |
Progress towards achievement of PDO | Satisfactory | 2011-12-28 |
Overall Implementation Progress (IP) | Moderately Satisfactory | 2011-12-28 |
Counterpart Funding | Satisfactory | 2011-12-28 |
Project Management | Moderately Satisfactory | 2011-12-28 |
Monitoring and Evaluation | Satisfactory | 2011-12-28 |
Financial Management | Moderately Satisfactory | 2011-12-28 |
INDICATOR | IMPLEMENTATION COMPLETION & RESULTS REPORT: 03-01-2013 |
---|---|
Outcomes | Moderately Satisfactory |
Risk to Development Outcome | Substantial |
Bank Performance | Moderately Satisfactory |
Borrower Performance | Moderately Satisfactory |
Government Performance | Moderately Satisfactory |
Implementing Agency | Moderately Satisfactory |
INDICATOR | ICR REVIEW: 12-30-2013 | PROJECT PERFORMANCE ASSESSMENT REPORT: |
---|---|---|
Outcome Rating | Moderately Satisfactory | N/a |
Risk To Development Outcome | Significant | N/a |
Bank Performance | Moderately Satisfactory | N/a |
Borrower Performance | Moderately Satisfactory | N/a |
Government Performance | Moderately Satisfactory | N/a |
Implementing Agency | Moderately Satisfactory | N/a |
Icr Quality | Satisfactory | N/a |
M&e Quality | Modest | N/a |
INDICATOR | BASELINE | CURRENT | TARGET |
---|
At least 15,000 orphans attend school regularly by July 2011 | Value | 15,000 | 10299 | 15,000 |
Date | December 30, 2004 | March 15, 2012 | March 31, 2012 | |
Comment | Not achieved. Activities supported only at the beginning school |
At least 9,000 PLWA medically eligible for treatment (CD4 count less than 200) are under ARV treatment by July 2011 | Value | 1,073 | 23963 | 9,000 |
Date | December 30, 2004 | March 15, 2012 | March 31, 2012 | |
Comment | Achieved by the program (not only MAP). The MAP is providing ARV through private pharmacies which is a major innovation. It isalsoproviding biological monitoring which is required prior to ARV treatment | The Global Fund was the main financier for ARVs. This was not planned during project preparation. The project did no reach theoriginal indicator because the government decided to mainly use the Global Fund resources to provide ARVs. |
55000 Persons aged 15 and older received counseling and testing (VCT) for HIV and received their test results (new indicator) | Value | n/a | 93870 | 55,000 |
Date | December 30, 2004 | March 15, 2012 | March 31, 2012 | |
Comment | Achieved |
15000 commercial sex workers and other MARP receiving services from subprojects | Value | n/a | 8600 | 15,000 |
Date | December 30, 2004 | June 12, 2009 | July 30, 2011 | |
Comment |
INDICATOR | BASELINE | CURRENT | TARGET |
---|
60% of HIV+ pregnant women assisted for prenatal care received ARV prophylaxis (PTME) by end of project | Value | 60% | 67% | 60% |
Date | December 30, 2004 | March 15, 2012 | March 31, 2012 | |
Comment | Achieved by the program (not only the MAP) |
257 reference centers (circles & communes) and CSCOM offer testing and counseling by end of project | Value | 257 | 320 | 257 |
Date | December 30, 2004 | March 15, 2012 | March 31, 2012 | |
Comment | Achieved |
160 reference centers (circles & communes) and CSCOM structures have means to dispose of medical waste by the end of the project | Value | na | 60 | 160 |
Date | December 30, 2004 | September 1, 2011 | March 31, 2012 | |
Comment | Not achieved. Activities ongoing. Equipments have been procured and are being installed |
At least 100 enterprises and business associations have implemented HIV/AIDS action plan by the end of the project | Value | 6 | 77 | 100 |
Date | December 30, 2004 | December 31, 2010 | July 30, 2011 | |
Comment | Not achieved. Activities ongoing |
Number of private centers offering VCT services increased from 15 to 55 | Value | 15 | 22 | 25 |
Date | December 31, 2004 | December 31, 2010 | July 30, 2011 | |
Comment | Not achieved. Activities ongoing |
7000 patients with access to treatment monitoring services by private laboratory (new indicator) | Value | n/a | 7000 | |
Date | December 30, 2004 | June 12, 2009 | December 30, 2011 | |
Comment | Achieved under the original project |
At least 25 sub-projects implemented among commercial sex workers and/or high risk groups (truck drivers, ambulatory vendors, military/police, etc) annually | Value | 2 | 50 | 50 |
Date | December 30, 2004 | December 31, 2010 | July 30, 2011 | |
Comment | Achieved |